Similar companies
Income Statement (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Gross Profit | -1.2M | 17.2% |
| Cost of Revenue | 1.2M | 17.2% |
| Operating expense | 3M | 17.8% |
| Net Income | -1.9M | 40.8% |
Balance Sheet (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Total Assets | 5.1M | 189.5% |
| Total Liabilities | 3.8M | 12.9% |
| Total Equity | 1.3M | 149.2% |
| Shares Outstanding | 2.3M | 202.8% |
Cash Flow (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Cash from operations | -4.3M | 311% |
| Cash from financing | 7.2M | 4049.4% |
EPS
Financial Highlights for Bio Path Holdings in Q2 '24
Gross Profit stood at -1.2M, marking a 17.2% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 1.2M, a -17.2% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 3M, showing a -17.8% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -1.9M, showing a 40.8% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's performance remained stable this quarter with no significant positive or negative changes in the key financial metrics.
